Guardant Health markets Shield, an FDA-approved blood test for primary colorectal cancer screening. The Harris Poll conducted the survey from Feb. 24-26, 2026, among 1,189 U.S. adults, ages 45 and ...
The survey results reveal strong enthusiasm for blood-based screening options among adults aged 45 and older, the group ...
Their makers claim they can detect dozens of cancer types — but some scientists say they could be missing many cancers or ...
AUSTIN, Texas--(BUSINESS WIRE)--Babson Diagnostics™, a science-first, health care technology company, today announced that a key piece of its BetterWay™ Blood Testing ecosystem has achieved 510(k) ...
A blood osmolality test measures the blood for the concentration of certain dissolved particles. This test can show whether a person has an irregular balance of fluids in their body. Osmolality tests ...
Pituitary tumors are atypical growths that develop in the pituitary gland. They are typically noncancerous. Doctors often use blood tests as a first step in diagnosing pituitary tumors. The pituitary ...
With the approval of anti-amyloid monoclonal antibodies to treat early-stage Alzheimer’s disease (AD), the need for accurate and early diagnosis is crucial. Blood-based biomarkers offer a promising ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results